Atlas Trials

Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia

Clinical trial NCT01854827 · COMPLETED

Trial details

NCT number
NCT01854827
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Biliary Atresia
Start date
2013-10-01
Primary completion
2016-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.